Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 7;107(1):384.
doi: 10.1093/jnci/dju384. Print 2015 Jan.

Germline mutations in shelterin complex genes are associated with familial glioma

Matthew N Bainbridge  1 , Georgina N Armstrong  1 , M Monica Gramatges  1 , Alison A Bertuch  1 , Shalini N Jhangiani  1 , Harsha Doddapaneni  1 , Lora Lewis  1 , Joseph Tombrello  1 , Spyros Tsavachidis  1 , Yanhong Liu  1 , Ali Jalali  1 , Sharon E Plon  1 , Ching C Lau  1 , Donald W Parsons  1 , Elizabeth B Claus  1 , Jill Barnholtz-Sloan  1 , Dora Il'yasova  1 , Joellen Schildkraut  1 , Francis Ali-Osman  1 , Siegal Sadetzki  1 , Christoffer Johansen  1 , Richard S Houlston  1 , Robert B Jenkins  1 , Daniel Lachance  1 , Sara H Olson  1 , Jonine L Bernstein  1 , Ryan T Merrell  1 , Margaret R Wrensch  1 , Kyle M Walsh  1 , Faith G Davis  1 , Rose Lai  1 , Sanjay Shete  1 , Kenneth Aldape  1 , Christopher I Amos  1 , Patricia A Thompson  1 , Donna M Muzny  1 , Richard A Gibbs  1 , Beatrice S Melin  1 , Melissa L Bondy  1 ; Gliogene Consortium
Affiliations

Germline mutations in shelterin complex genes are associated with familial glioma

Matthew N Bainbridge et al. J Natl Cancer Inst. .

Abstract

Gliomas are the most common brain tumor, with several histological subtypes of various malignancy grade. The genetic contribution to familial glioma is not well understood. Using whole exome sequencing of 90 individuals from 55 families, we identified two families with mutations in POT1 (p.G95C, p.E450X), a member of the telomere shelterin complex, shared by both affected individuals in each family and predicted to impact DNA binding and TPP1 binding, respectively. Validation in a separate cohort of 264 individuals from 246 families identified an additional mutation in POT1 (p.D617Efs), also predicted to disrupt TPP1 binding. All families with POT1 mutations had affected members with oligodendroglioma, a specific subtype of glioma more sensitive to irradiation. These findings are important for understanding the origin of glioma and could have importance for the future diagnostics and treatment of glioma.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
POT1 mutations in familial glioma pedigrees. Individuals with glioma are shown as filled. Individuals with other cancers are shown as half filled. Disease and age in years at first diagnosis are given underneath the symbol, with current age or age at death (+) above it. Deceased individuals are designated with a slash through the symbol. Glioma type is shown (AnaO = anaplastic oligodendroglioma; Astro = astrocytoma; GBM = glioblastoma multiforme; Glioma = glioma unknown; Oligo = oligodendroglioma). Other cancers in the pedigree are shown (CoC = colon cancer; LC = lung cancer; Leuk = leukemia; Mel = melanoma). Mutations for all sequenced individuals are shown or listed as WT (wild-type).
Figure 2.
Figure 2.
Germline variants identified in this study (red arrow) and associated with melanoma (blue arrow) in OB1 and OB2 regions (green) and TPP1 binding region (orange) in POT1. † indicates variant was also seen in a tumor sample. OB1/2 = Oligonucleotide binding; TPP1 = tripeptidyl peptidase I.
See this image and copyright information in PMC

Comment in

  • RE: Germline Mutations in Shelterin Complex Genes Are Associated With Familial Glioma.
    Cooke JG. Cooke JG. J Natl Cancer Inst. 2015 Jun 16;107(8):djv173. doi: 10.1093/jnci/djv173. Print 2015 Aug. J Natl Cancer Inst. 2015. PMID: 26079288 Free PMC article. No abstract available.
  • Response.
    Bainbridge M, Bondy ML. Bainbridge M, et al. J Natl Cancer Inst. 2015 Jun 16;107(8):djv174. doi: 10.1093/jnci/djv174. Print 2015 Aug. J Natl Cancer Inst. 2015. PMID: 26079289 Free PMC article. No abstract available.

Similar articles

See all similar articles

Cited by

  • POT1 Regulates Proliferation and Confers Sexual Dimorphism in Glioma.
    Jalali A, Yu K, Beechar V, Bosquez Huerta NA, Grichuk A, Mehra D, Lozzi B, Kong K, Scott KL, Rao G, Bainbridge MN, Bondy ML, Deneen B. Jalali A, et al. Cancer Res. 2021 May 15;81(10):2703-2713. doi: 10.1158/0008-5472.CAN-20-3755. Epub 2021 Mar 29. Cancer Res. 2021. PMID: 33782098 Free PMC article.
  • Role of POT1 in Human Cancer.
    Wu Y, Poulos RC, Reddel RR. Wu Y, et al. Cancers (Basel). 2020 Sep 24;12(10):2739. doi: 10.3390/cancers12102739. Cancers (Basel). 2020. PMID: 32987645 Free PMC article. Review.
  • Stop pulling my strings - what telomeres taught us about the DNA damage response.
    Lazzerini-Denchi E, Sfeir A. Lazzerini-Denchi E, et al. Nat Rev Mol Cell Biol. 2016 Jun;17(6):364-78. doi: 10.1038/nrm.2016.43. Epub 2016 May 11. Nat Rev Mol Cell Biol. 2016. PMID: 27165790 Free PMC article. Review.
  • Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
    Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR, O'Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM, Prados MD, Wiemels J, Wiencke JK, Wrensch MR, Jenkins RB. Eckel-Passow JE, et al. N Engl J Med. 2015 Jun 25;372(26):2499-508. doi: 10.1056/NEJMoa1407279. Epub 2015 Jun 10. N Engl J Med. 2015. PMID: 26061753 Free PMC article.
  • Case report: Germline POT1 mutation in a patient with GIST and lung adenocarcinoma.
    Martino S, De Summa S, Pilato B, Digennaro M, Laera L, Tommasi S, Patruno M. Martino S, et al. Front Oncol. 2024 Aug 2;14:1419739. doi: 10.3389/fonc.2024.1419739. eCollection 2024. Front Oncol. 2024. PMID: 39156708 Free PMC article.
See all "Cited by" articles

References

    1. Sadetzki S, Bruchim R, Oberman B, et al. Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. Eur J Cancer Oxf Engl 1990. 2013;49(6):1335–1345. - PMC - PubMed
    1. Ostrom Q, Bauchet L, Davis F, Fisher J, Langer C, Pekmezci M. The epidemiology of glioma in adults: a review. Neuro-Onc. 2014;16(7):896–913. - PMC - PubMed
    1. Xie H, Wu X, Wang S, et al. Long telomeres in peripheral blood leukocytes are associated with an increased risk of soft tissue sarcoma. Cancer. 2013;119(10):1885–1891. - PMC - PubMed
    1. Wang S, Chen Y, Qu F, et al. Association between leukocyte telomere length and glioma risk: a case-control study. Neuro-Oncol. 2014;16(4):505–512. - PMC - PubMed
    1. Walcott F, Rajaraman P, Gadalla SM, et al. Telomere length and risk of glioma. Cancer Epidemiol. 2013;37(6):935–938. - PMC - PubMed

Publication types